MS&AD Insurance Group Holdings Inc. (MSADY) Is Up 2.06% in One Week: What You Should Know
https://www.zacks.com/stock/news/2282897/ms-ad-insurance-group-holdings-inc-msady-is-up-2-06-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2282897
Jun 03, 2024 - Does MS&AD Insurance Group Holdings Inc. (MSADY) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
How Much Upside is Left in The ONE Group Hospitality (STKS)? Wall Street Analysts Think 47.5%
https://www.zacks.com/stock/news/2282728/how-much-upside-is-left-in-the-one-group-hospitality-stks-wall-street-analysts-think-47-5?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2282728
Jun 03, 2024 - The consensus price target hints at a 47.5% upside potential for The ONE Group Hospitality (STKS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
0
Bill Ackman selling stake in Pershing Square at $10.5 billion valuation, aiming for IPO one day
https://www.cnbc.com/2024/05/31/ackman-selling-stake-in-pershing-square-at-10point5-billion-valuation-aiming-for-ipo.html
May 31, 2024 - Billionaire investor Bill Ackman is selling a 10% stake in Pershing Square, aiming to eventually take his investment firm public.
0
Optum joins FDA, manufacturer in recalling infusion pumps that killed one patient
https://www.startribune.com/optum-unitedhealth-group-infutronix-infusion-pump-recall/600369835/
May 30, 2024 - The devices, which Massachusetts-based InfuTronix makes, deliver medications and fluids to patients via IV or injection.
0
TransDigm Group (TDG) Is Up 4.52% in One Week: What You Should Know
https://www.zacks.com/stock/news/2281583/transdigm-group-tdg-is-up-4-52-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2281583
May 30, 2024 - Does TransDigm Group (TDG) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
BlackRock-backed fintech Trustly says IPO still at least one year out even as profits jump 51%
https://www.cnbc.com/2024/05/30/trustly-posts-51percent-profit-jump-ceo-says-ipo-at-least-2-years-out.html
May 30, 2024 - Johan Tjarnberg, CEO of Trustly, told CNBC his firm still needs time to prove the value of its open banking tech to investors before going public.
0
WestRock (WRK) Is Up 2.25% in One Week: What You Should Know
https://www.zacks.com/stock/news/2280825/westrock-wrk-is-up-2-25-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2280825
May 29, 2024 - Does WestRock (WRK) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
https://www.fool.com/investing/2024/05/29/astrazeneca-just-massively-one-upped-pfizer-heres/?source=iedfolrf0000001
May 29, 2024 - Both businesses have road maps for the future, but one is better.
0
Apellis (APLS) Posts Upbeat One-Year Kidney Diseases Study Data
https://www.zacks.com/stock/news/2279677/apellis-apls-posts-upbeat-one-year-kidney-diseases-study-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2279677
May 27, 2024 - Apellis (APLS) reports positive one-year data from the mid-stage study evaluating systemic pegcetacoplan to treat two rare and debilitating kidney diseases.
0
Primo (PRMW) Is Up 5.30% in One Week: What You Should Know
https://www.zacks.com/stock/news/2279637/primo-prmw-is-up-5-30-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2279637
May 27, 2024 - Does Primo (PRMW) have what it takes to be a top stock pick for momentum investors? Let's find out.
0